Cite
HARVARD Citation
Cottu, P. et al. (2018). Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer. Annals of oncology. pp. 2334-2340. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cottu, P. et al. (2018). Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer. Annals of oncology. pp. 2334-2340. [Online].